Autoantibody biomarker opens a new gateway for cancer diagnosis
- 30 January 2006
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (4) , 398-403
- https://doi.org/10.1016/j.bbadis.2005.12.010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vitro and in vivo Effects of Combination of Trastuzumab (Herceptin) and Tamoxifen in Breast CancerBreast Cancer Research and Treatment, 2005
- Human Chorionic Gonadotropin Decreases Proliferation and Invasion of Breast Cancer MCF-7 Cells by Inhibiting NF-κB and AP-1 ActivationJournal of Biological Chemistry, 2004
- Extracellular cAMP-dependent protein kinase (ECPKA) in melanomaCancer Letters, 2004
- Tumor markers and colorectal cancer: Utility in managementJournal of Surgical Oncology, 2003
- A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal CancerNew England Journal of Medicine, 2003
- Extracellular protein kinase A as a cancer biomarker: Its expression by tumor cells and reversal by a myristate-lacking Cα and RIIβ subunit overexpressionProceedings of the National Academy of Sciences, 2000
- Circulating antibodies against c‐MYC oncogene product in sera of colorectal cancer patientsInternational Journal of Cancer, 1990
- Human Cancer-Associated Antigens: Present Status and Implications for ImmunodiagnosisAdvances in Cancer Research, 1985
- Detection of antibodies against the cellular protein p53 in sera from patients with breast cancerInternational Journal of Cancer, 1982
- Phosphorylation-Dephosphorylation of EnzymesAnnual Review of Biochemistry, 1979